Enabling Routine and Reproducible Intact Mass Analysis When Data Integrity Matters

Significance of the Topic

Mass spectrometric methods for intact and subunit-level protein analysis play a critical role in biotherapeutic development and quality control, offering precise data on molecular integrity, post-translational modifications and batch-to-batch consistency.

Objectives and Study Overview

This application note evaluates an end-to-end workflow for intact antibody and subunit mass analysis using an integrated LC-MS system, emphasizing automation, reproducibility and regulatory compliance in routine laboratory settings.

Used Instrumentation

• ACQUITY UPLC I-Class PLUS System
• ACQUITY RDa Mass Detector
• TUV Optical Detector (UV 280 nm)
• UNIFI Scientific Informatics System v1.9.4
• Columns: ACQUITY UPLC-BEH300 C4 (2.1 × 50 mm), BioResolve RP mAb Polyphenyl 450 (2.1 × 50 mm)

Methodology

A standard humanized monoclonal antibody and its IdeS-digested subunits were prepared at defined concentrations and analyzed via reversed-phase UPLC at 80 °C. Intact protein separations employed gradients of water and acetonitrile with 0.1% formic acid or TFA. MS scans were acquired in positive ion mode over m/z 400–7000 at 2 Hz scan rate, with optimized cone and capillary voltages and desolvation temperatures. Data capture, deconvolution (MaxEnt1) and reporting were fully automated through UNIFI workflows.

Key Results and Discussion

• Intact mAb spectra exhibited clear charge state distributions and enabled deconvolution of five major glycoforms with consistent relative abundances (RSD < 2.5% across 13 injections).
• Mobile phases with 0.1% TFA required increased sample load and higher declustering voltage to match formic acid sensitivity, demonstrating flexibility for UV-based laboratory preferences.
• Subunit analysis resolved scFc, light chain and Fd fragments with high signal-to-noise, yielding accurate mass assignments and glycoform profiles in a 15 min run.

Benefits and Practical Applications

The integrated system reduces user intervention in instrument tuning, data processing and method transfer, enabling non-expert operators to generate high-quality mass data. It supports late-stage development, QC labs and regulated environments, streamlining method development and regulatory submissions.

Future Trends and Opportunities

Automation of intact mass workflows will expand into high-throughput screening, real-time release testing, and integration with orthogonal techniques (e.g., peptide mapping). Advances in informatics will further simplify data interpretation, facilitate multi-attribute monitoring and support digital lab ecosystems.

Conclusion

The BioAccord LC-MS platform, coupled with UNIFI informatics, delivers robust, reproducible intact and subunit mass analyses, reducing complexity and enabling broader use in regulated and research laboratories for biotherapeutic characterization.

References

1. Rogstad S. et al. J Am Soc Mass Spectrom. 2017;28(5):786–794.
2. Sokolowska I. et al. MAbs. 2017;9:498–505.
3. Xu W. et al. MAbs. 2017;9:1186–1196.